Novavax
NVAX
#5049
Rank
โ‚ฌ1.38 B
Marketcap
8,52ย โ‚ฌ
Share price
0.98%
Change (1 day)
17.58%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): โ‚ฌ0.34 Billion

According to Novavax's latest financial reports the company's current earnings are โ‚ฌ1.02 Billion. In 2024 the company made an earning of -โ‚ฌ0.14 Billion, an increase over its 2023 earnings that were of -โ‚ฌ0.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.34 B-357.91%
2024 -โ‚ฌ0.14 Billion-70.39%
2023 -โ‚ฌ0.46 Billion-16.59%
2022 -โ‚ฌ0.55 Billion-62.58%
2021 -โ‚ฌ1.47 Billion320.54%
2020 -โ‚ฌ0.35 Billion234.22%
2019 -โ‚ฌ0.11 Billion-30.17%
2018 -โ‚ฌ0.15 Billion1.69%
2017 -โ‚ฌ0.15 Billion-36.44%
2016 -โ‚ฌ0.24 Billion70.4%
2015 -โ‚ฌ0.14 Billion89.27%
2014 -โ‚ฌ71.75 Million59.83%
2013 -โ‚ฌ44.89 Million81.9%
2012 -โ‚ฌ24.68 Million50.33%
2011 -โ‚ฌ16.42 Million
2009 -โ‚ฌ32.4 Million8.8%
2008 -โ‚ฌ29.78 Million18.01%
2007 -โ‚ฌ25.24 Million18.33%
2006 -โ‚ฌ21.33 Million168.31%
2005 -โ‚ฌ7.95 Million-62.51%
2004 -โ‚ฌ21.21 Million52.4%
2003 -โ‚ฌ13.92 Million-28.21%
2002 -โ‚ฌ19.38 Million
2000 -โ‚ฌ11.05 Million177%
1999 -โ‚ฌ3.99 Million-11.54%
1998 -โ‚ฌ4.51 Million10.64%
1997 -โ‚ฌ4.08 Million-9.62%
1996 -โ‚ฌ4.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚ฌ14.17 B 4,260.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ10.27 B 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ11.34 B 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ8.07 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚ฌ0.22 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.23 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ17.9 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚ฌ7.05 Million-102.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚ฌ5.74 Million-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA